Methods and biomarkers for detection of bladder cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9797016
SERIAL NO

13879545

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to methods and biomarkers (e.g., epigenetic biomarkers) for detection of bladder cancer in biological samples (e.g., tissue samples, urine samples, urine sediments). In some embodiments, methods and biomarkers of the present invention find use in discriminating between bladder cancer, prostate cancer and renal epithelial tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSLO UNIVERSITETSSYKEHUS HFP O BOX 4950 NYDALEN N-0424 OSLO N-0424

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Costa, Vera L Aulnay-sous-Bois, FR 2 2
Henrique, Rui Maia, PT 2 2
Jeronimo, Carmen Maia, PT 3 2
Lind, Guro Elisabeth Oslo, NO 5 3
Lothe, Ragnhild A Oslo, NO 12 9
Skotheim, Rolf Inge Oslo, NO 5 3
Teixeira, Manuel R Vila Nova de Gaia, PT 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00